Ovid Therapeutics

+$0.02 (+0.54%) Today
$0.00 (0.00%) As of 8:01 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OVID and other ETFs, options, and stocks.

About OVID

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.

CEO
Jeremy Max Levin
Employees
67
Headquarters
New York, New York
Founded
2014

OVID Key Statistics

Market Cap
302.69M
Price-Earnings Ratio
2.48
Dividend Yield
—
Average Volume
337.99K
High Today
$3.76
Low Today
$3.62
Open Price
$3.68
Volume
227.98K
52 Week High
$8.37
52 Week Low
$2.25

OVID Earnings

-$0.41
$0.57
$1.55
$2.53
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure